GLP-1 Agonist Comparison 2026: Semaglutide vs Tirzepatide vs Retatrutide vs Orforglipron

Compare four GLP-1 receptor agonists in 2026: semaglutide, tirzepatide, retatrutide, and orforglipron. Chemical structures, receptor profiles, clinical trial data, and key differences.

For laboratory research use only. Not for human consumption.

ChemVerify is an independent verification platform for research peptide sources. We provide third-party COA and HPLC verification, price comparison across verified vendors, and educational resources for laboratory researchers.